These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 2767613

  • 1. [Anti-tachycardiac effect of a direct-acting vasodilator, budralazine].
    Yoshioka M.
    Hokkaido Igaku Zasshi; 1989 May; 64(3):255-68. PubMed ID: 2767613
    [Abstract] [Full Text] [Related]

  • 2. The anti-tachycardic mechanism of a direct-acting vasodilator, budralazine, in rats.
    Yoshioka M, Minami M, Saito H.
    Clin Exp Hypertens A; 1991 May; 13(5):1107-14. PubMed ID: 1773498
    [Abstract] [Full Text] [Related]

  • 3. Central sympathoinhibitory action of a direct-acting vasodilator, budralazine, in anesthetized rats.
    Yoshioka M, Yahagi H, Minami M, Saito H.
    Jpn J Pharmacol; 1987 Jun; 44(2):187-96. PubMed ID: 3656776
    [Abstract] [Full Text] [Related]

  • 4. Pre- and postsynaptic alpha-adrenergic effects of the antihypertensive drug budralazine.
    Shibamura S, Chiba T, Suzuki I, Akashi A.
    Arzneimittelforschung; 1981 Jun; 31(7):1076-9. PubMed ID: 6268123
    [Abstract] [Full Text] [Related]

  • 5. Central sympathoinhibitory action of a new type of alpha-1 adrenoceptor antagonist, YM-617, in rats.
    Yoshioka M, Togashi H, Abe M, Ikeda T, Matsumoto M, Saito H.
    J Pharmacol Exp Ther; 1990 May; 253(2):427-31. PubMed ID: 1692588
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of a muscarinic (M1) receptor agonist on sympathetic nerve activity in rats].
    Saito Y.
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):190-204. PubMed ID: 8509063
    [Abstract] [Full Text] [Related]

  • 9. Effect of SM-2470, a newly synthetized alpha 1-adrenoceptor antagonist, on sympathetic nerve activity in anesthetized rats.
    Yoshioka M, Matsumoto M, Togashi H, Abe M, Ikeda T, Morii K, Minami M, Saito H.
    Arch Int Pharmacodyn Ther; 1988 Mar; 293():162-74. PubMed ID: 2901824
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antihypertensive and general pharmacological properties of budralazine.
    Chiba T, Shibamura S, Tanaka M, Yamasaki T, Hashimoto H, Kurebayashi Y, Kasai Y, Ryokawa Y, Tamura K, Hirohashi M, Akashi A.
    Arzneimittelforschung; 1981 Mar; 31(7):1080-7. PubMed ID: 7023495
    [Abstract] [Full Text] [Related]

  • 12. Discrepancy between central sympathoinhibitory action and peripheral hemodynamic effects of pindolol in anesthetized rats.
    Yoshioka M, Togashi H, Matsumoto M, Tochihara M, Minami M, Saito H.
    Hokkaido Igaku Zasshi; 1988 Nov; 63(6):957-62. PubMed ID: 3248773
    [Abstract] [Full Text] [Related]

  • 13. Pharmacology of budralazine, a new antihypertensive drug.
    Akashi A, Chiba T, Suzuki I, Hashimoto H.
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):134-46. PubMed ID: 736687
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the vasodilator action of antihypertensive drug budralazine.
    Chiba T, Hirohashi M, Suzuki I, Tanaka S, Watanabe K, Akashi A.
    Arzneimittelforschung; 1983 Sep; 33(1):112-6. PubMed ID: 6299307
    [Abstract] [Full Text] [Related]

  • 15. Hypotensive and cardiovascular action of budralazine in unanesthetized and unrestrained dogs.
    Konno K, Nonaka K, Ueno A.
    Arzneimittelforschung; 1981 Sep; 31(7):1072-5. PubMed ID: 7196755
    [Abstract] [Full Text] [Related]

  • 16. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.
    Armstrong JM, Lefèvre-Borg F, Scatton B, Cavero I.
    J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404
    [Abstract] [Full Text] [Related]

  • 17. Failure of naloxone to reduce clonidine-induced changes in blood pressure, heart rate and sympathetic nerve firing in cats.
    Shropshire AT, Wendt RL.
    J Pharmacol Exp Ther; 1983 Mar; 224(3):494-500. PubMed ID: 6827474
    [Abstract] [Full Text] [Related]

  • 18. Effects of acute and chronic administration of idazoxan on blood pressure and plasma catecholamine concentrations of rats.
    Harland D, Brown MJ.
    J Pharmacol Exp Ther; 1988 Apr; 245(1):265-73. PubMed ID: 3361445
    [Abstract] [Full Text] [Related]

  • 19. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI, Hofferber E, Stenzel W.
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [Abstract] [Full Text] [Related]

  • 20. Study of the in vivo and in vitro cardiovascular effects of a hydralazine-like vasodilator agent (HPS-10) in normotensive rats.
    Orallo F.
    Br J Pharmacol; 1997 Aug; 121(8):1627-36. PubMed ID: 9283696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.